🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

Baird lowers Stericycle shares target amid leverage concerns

EditorEmilio Ghigini
Published 04/26/2024, 09:48 PM

Friday - Baird has adjusted its outlook on Stericycle (NASDAQ:SRCL) stock, a waste management company, by reducing the price target from $62 to $55 while maintaining a neutral rating.

The firm noted that concerns over the company's leverage might have influenced the stock's recent performance. Management at Stericycle hinted at increased leverage, which, coupled with a narrow margin of error concerning financial covenants and higher Days Sales Outstanding (DSO), likely contributed to investor unease.

In the midst of these concerns, Stericycle's management announced the launch of a new subscription-based service offering named SID. This development was highlighted as a positive move with potential benefits for the company.

Despite these changes, Baird has chosen to retain a neutral stance on Stericycle's stock during what it describes as the early post-ERP deployment period. The firm acknowledges that Stericycle presents an attractive long-term improvement opportunity but prefers to maintain a cautious approach until more substantial progress is observed.

InvestingPro Insights

As Stericycle (NASDAQ:SRCL) navigates through its post-ERP deployment period with the launch of its new SID service, investors are closely monitoring the company's financial health and market performance. According to real-time data from InvestingPro, Stericycle has a market capitalization of approximately $4.3 billion. Despite a challenging revenue growth outlook, with a -3.12% change over the last twelve months as of Q1 2024, the company's gross profit margin remains robust at 37.79%.

InvestingPro Tips suggest that Stericycle's net income is expected to grow this year, which could signal a turnaround for the company that has not been profitable over the last twelve months. Additionally, the Relative Strength Index (RSI) indicates that the stock may be in oversold territory, presenting a potential entry point for investors. Analysts forecast that the company will achieve profitability this year, a critical factor that could influence the stock's trajectory. However, it's worth noting that Stericycle does not currently pay a dividend to shareholders, which may be a consideration for income-focused investors.

For those looking to delve deeper into Stericycle's prospects, InvestingPro offers a wealth of additional tips. By using the coupon code PRONEWS24, readers can get an extra 10% off a yearly or biyearly Pro and Pro+ subscription, providing access to even more expert analysis and data to inform investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.